Equity · Healthcare
NNVC
NanoViricides, Inc. · NYSE American
$1.76
−0.85% 1D
Finazon · prior-day close
Price · Chart
Chart by TradingView
Crowd sentiment on NNVC · 30d
Bullish
0%
Neutral
100%
Bearish
0%
Across 0 classified mentions in the last 30 days, crowd sentiment for NNVC sits roughly neutral, with 0% reading bullish against 0% bearish across the classified sample.
NNVC earnings
Date
Period
EPS
Revenue
31 Mar 2026
Q3 2026
$-0.09
—
31 Dec 2025
Q2 2026
$-0.11
—
30 Sep 2025
Q1 2026
$-0.10
—
30 Jun 2025
FY 2025
$-0.63
—
Reported figures & scheduled dates · SEC EDGAR filings